GMR SOLUTIONS INC (GMRS)
NYSEIndustrialsMedical - Care FacilitiesSnapshot 2026-09-04
$13.46+0.37%
Close 2026-09-04 · 1-day change
NYSEIndustrialsMedical - Care FacilitiesSnapshot 2026-09-04
QuarterlyIQ Insights · GMRS
What must go right, what could break, what the price assumes, and what evidence comes next.
The current health of the standing investment case.
No current thesis-health read is available for this company.
One-year growth currently built into the price, compared with our model's estimate.
| Measure | Marker shape | Value |
|---|---|---|
| Growth built into the price | circle | -32.7% |
| Our one-year growth estimate | diamond |
For each item: what to watch, what would become a concern, and what would make it less concerning.
A reporting-risk estimate, not a forecast of the stock-price response.
Historical relationships that met the evidence threshold. They do not prove cause or forecast a move.
No outside relationship met the current evidence threshold.
Based on historical daily prices through 2026-09-04.
Past price behavior in dollars on a $10,000 position. This does not measure permanent business risk.
How much price usually moves either way.
Use the underlying financial and sector pages to investigate the cause.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
| 79.0% |
Growth built into the price is above our model estimate.
The price assumes 111.7 percentage points less one-year growth.
The one-year revenue growth assumption on Valuation.
Worth watching into the next print: this name has been missing across recent quarters and missed its most recent quarter. A fundamental tilt, not a price call.
Model as of 2026-09-04 · Compared with 26 industry peers · Company calendar date is not available
GMRS — earnings miss
Dated 2026-08-12
Results of Operations and Financial Condition. On August 12, 2026, GMR Solutions Inc. (the “Company”) issued a press release announcing its financial results for the three and six months ended June 30, 2026. A copy of the Company’s press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K. The information contained in this Item 2.02, including Exhibit 99.1 attached hereto, is being furnished and shall not be deemed filed for purposes of Section 18 of the Securities Exchang…
Why it matters: This revenue range is key to achieving full-year guidance of $5.89B to $6.18B.
Supportive ifQ2 revenue reported between $1.5 billion and $1.55 billion.
Worry ifQ2 revenue reported below $1.5 billion.
Why it matters: Growth in operating income is key to maintaining strong income growth.
Supportive ifQ2 operating income was more than $218.9 million.
Worry ifQ2 operating income was less than $218.9 million.
Why it matters: An update on revenue guidance will show if GMR can meet its full-year target.
Watch forManagement reaffirms full-year revenue guidance of $5.89B to $6.18B in Q3.
Also watch forManagement cuts full-year revenue guidance to below $5.89B.
Why it matters: A smaller net loss shows better financial health and efficiency. This can help investors.
Supportive ifNet loss decreases to less than $28 million in Q3.
Worry ifNet loss increases beyond $28 million in Q3.
A larger daily loss that occurred about once in every 20 trading days.
Deepest peak-to-trough drop in the last year.
| Measure | Value | Meaning |
|---|---|---|
| Typical day | ±$250 on $10,000 · ±2.5% | How much price usually moves either way. |
| Bad day | $618 loss on $10,000 · 6.2% | A larger daily loss that occurred about once in every 20 trading days. |
| Largest peak-to-trough drop in the past year | $2,440 loss on $10,000 · 24.4% | Deepest peak-to-trough drop in the last year. |
Past year. 1.00 means similar movement; 1.20 means about 20% more.
Past year. 1.00 means similar movement to the sector. This is secondary context.
Latest 30 trading days, shown as an annual percentage.
Latest 252 trading days, shown as an annual percentage.
20-trading-day average in US dollars.
Trading days used by the source risk snapshot.
Past results, not a forecast. Not investment advice.
Why it matters: Net income trends show how well GMR manages costs and makes more money.
Worry ifNet income is better, returning to positive numbers in Q3.
Less concerning ifNet income remains negative or worsens in Q3.
Why it matters: More patient visits show demand for GMR's services and its health.
Supportive ifTotal patient encounters increase year over year by more than 2% in Q3.
Worry ifTotal patient encounters decline year over year.
Why it matters: Adjusted EBITDA shows if GMR is making money despite problems.
Supportive ifAdjusted EBITDA for Q3 is over $284.5 million.
Worry ifAdjusted EBITDA for Q3 falls below $250 million.
Why it matters: More patient encounters show demand for GMR's services and how well it is doing.
Watch forPatient encounters grow year over year by more than 3% in Q3.
Also watch forPatient encounters decline year over year by more than 2% in Q3.
Why it matters: Getting new business will help revenue growth and prove GMR's market strength.
Supportive ifNew contracts or partnerships announced that add over $50 million in revenue.
Worry ifNo new business wins announced in the next quarter.